About 100 reports

  • Stressful Lifestyles and Virulent Flu Cases Boost Antacids and Diarrhoeal Remedies

As a result, stress tends to cause more headaches and gastrointestinal somatisation for women.

  • Gastrointestinal Drug
  • OTC
  • Italy
  • Demand
  • DIGESTIVE REMEDIES IN GERMANY - CATEGORY ANALYSIS
  • Common Problems of Modern Society: Hectic Lifestyles and Food Allergies

One of the reasons behind this weaker performance was the fitness trend, especially among the younger population.

  • Gastrointestinal Drug
  • OTC
  • Germany
  • Demand
  • Increased Interest in Herbal/traditional Digestive Remedies

The only OTC products limited in terms of quantity are medicines containing pseudoephedrine, codeine or dextromethorphan - consumers are allowed to buy one small package in one pharmacy without a prescription.

  • Gastrointestinal Drug
  • OTC
  • Poland
  • Demand

The US has one of the most liberal approaches to OTC distribution in the world.

  • Gastrointestinal Drug
  • OTC
  • United States
  • Demand

Domestic players tend to focus on digestive remedies, alleviating symptoms such as stomach ulcers and gastrointestinal infection.

  • Gastrointestinal Drug
  • OTC
  • Laos
  • Thailand
  • Demand

Lebanon is one of the largest consumers of consumer health products per capita in the Middle East and North Africa (MENA) region.

  • Gastrointestinal Drug
  • OTC
  • Vitamin
  • Lebanon
  • Demand

In addition, most of the rural majority lack access to either refrigeration appliances or electricity, further putting them at risk of gastrointestinal infections.

  • Gastrointestinal Drug
  • OTC
  • Vitamin
  • Cambodia
  • Demand
  • Other gastrointestinal disease, total (000s)
  • IBS patients with gastroenteritis, total (000s)

Other gastrointestinal disease, total (##s) Table ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pathology
  • Italy

Moreover, vitamins and dietary supplements must not be advertised for any specific medicinal purpose, such as treating cardiovascular or gastrointestinal disease.

  • Gastrointestinal Drug
  • Singapore
  • Demand
  • GlaxoSmithKline plc
  • Singapore Pte Ltd

The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/ IND, pre registration, phase ##, phase ##, and phase ## trials).

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pathology
  • Pharmaceutical

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • APAC
  • North America
  • World
  • Forecast
  • Clinical Trial profile. 43 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2020*
  • PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2019*

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Drug Development
  • Gastrointestinal Drug
  • World
  • Zantac
  • Market trends

Safe if provided warnings are followed ##.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Target
  • Clinical Trial profile. 309 Trial Title

PROPORTION OF NAUSEA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2019* PROPORTION OF NAUSEA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2019* PROPORTION OF NAUSEA TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2019* Source: GlobalData' s P

  • Clinical Trial
  • Drug Development
  • Gastrointestinal Drug
  • Therapy
  • World
  • Clinical Trial profile. 149 Trial Title
  • Target

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Target

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • China
  • World
  • APR 19, 2017: REDHILL BIOPHARMA TO HOST R&D DAY ON BEKINDA FOR ACUTE GASTROENTERITIS AND IBS-D
  • FEATURED NEWS & PRESS RELEASES

IBS is one of the most common gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • United States
  • Product Initiative
  • Clinical Trial profile. 303 Trial Title
  • Clinical Trial profile. 499 Trial Title

Menarini Industrie Farmaceutiche Riunite Srl APR Applied Pharma ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Research SA ## ## ## ## ## ondansetron alone or in combination has the highest number of post operative nausea and vomiting ongoing clinical trials.

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • PROPORTION OF IRRITABLE BOWEL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2020*
  • PROPORTION OF IRRITABLE BOWEL SYNDROME TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2020*

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Gastrointestinal Drug
  • Opioid
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2020*
  • PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2020*

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Gastrointestinal Drug
  • Opioid
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 7 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited

GASTROINTESTINAL (GI) DISORDERS ##. ##. ##.

  • Gastrointestinal Drug
  • North America
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC
  • JAN 12, 2017: REDHILL BIOPHARMA PROVIDES MILESTONE UPDATE ON BEKINDA
  • OCT 14, 2015: REDHILL BIOPHARMA PROVIDES UPDATE ON BEKINDA ONGOING PHASE III STUDY FOR GASTROENTERITIS AND ANNOUNCES PLANNED PHASE II STUDY FOR IBS-D

IBS IS ONE OF THE MOST COMMON GASTROINTESTINAL DISORDERS.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 190 Trial Title
  • Official Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Gastrointestinal Drug
  • Therapy
  • World
  • Merck & Co., Inc.
  • Target
  • Clinical Trial profile. 240 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Target
  • Clinical Trial profile. 15 Trial Title

Pylori Negative Healthy Volunteers GDCT## GDC##, ## Gastrointestinal Acidity, Unspecified Gastrointestinal Disorders Completed Phase I Interventional (aspirin DR + omeprazole) Aralez Pharmaceuticals Inc ## May 2012 ## ## ## Potassium Transporting ATPase Alpha Cha

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative

GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide.

  • Gastrointestinal Drug
  • OTC
  • Therapy
  • United States
  • Market Size
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF TRAVELER'S DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF TRAVELER'S DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS

## ## ## ## ## ## Germany ## ## ## ## ## ## Japan ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## Italy ## ## ## ## ## ## Canada Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a tim

  • Drug Development
  • Gastrointestinal Drug
  • Healthcare
  • World
  • Product Initiative